Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

NCT01001221 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Maximum tolerated dose not able to be determined

Conditions

Neoplasms, Malignant

Interventions

DRUG: cabazitaxel
DRUG: gemcitabine

Sponsor

Sanofi